期刊文献+

骨髓基质细胞对急性淋巴细胞白血病细胞化疗敏感性的影响 被引量:3

Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells
原文传递
导出
摘要 目的探讨骨髓基质细胞及其细胞外基质成分和基质细胞因子对急性淋巴细胞白血病细胞Sup-B15阿糖胞苷(Ara-C)化疗敏感性的影响。方法构建急性淋巴细胞白血病细胞Sup-B15与骨髓基质细胞OP9共培养模型。将Sup-B15细胞分为Sup-B15与OP9共培养组、Sup-B15与灭活的OP9共培养组、Sup-B15单独培养组、Sup-B15与OP9共培养液组、OP9单独培养液组和Sup-B15单独培养液组。采用细胞计数盒8法观察不同浓度的Ara-C对各组Sup-B15细胞增殖活力的影响;采用流式细胞仪检测Ara-C对各组Sup-B15细胞凋亡的影响;采用Western blot法检测各组Sup-B15细胞中bcl-2蛋白的表达情况。结果CCK-8法检测结果显示,随着Ara-C浓度的增加,Ara-C对Sup-B15细胞的抑制率也随之增强。不同浓度Ara-C处理各组Sup-B15细胞48 h,Sup-B15与OP9共培养组、Sup-B15与灭活的OP9共培养组的IC50分别为0.510和0.339 μg/ml,均明显高于Sup-B15单独培养组的IC50(0.091 μg/ml,P〈0.05)。Sup-B15与OP9共培养液组的IC50为0.204 μg/ml,明显高于OP9单独培养液组(0.087 μg/ml,P〈0.05)和Sup-B15单独培养液组的IC50值(0.097 μg/ml,P〈0.05)。流式细胞仪检测结果显示,0.1 μg/ml Ara-C处理各组Sup-B15细胞24 h后,Sup-B15与OP9共培养组、Sup-B15与灭活的OP9共培养组、Sup-B15单独培养组的早期凋亡细胞百分数分别为(6.67±2.19)%、(8.95±3.04)%和(20.46±2.63)%,Sup-B15与OP9共培养组、Sup-B15与灭活的OP9共培养组的早期凋亡细胞百分数均明显低于Sup-B15单独培养组,差异有统计学意义(P〈0.05)。Sup-B15与OP9共培养液组、OP9单独培养液组和Sup-B15单独培养液组的早期凋亡细胞百分数分别为(11.16±2.97)%、(22.08±2.71)%和(19.25±1.57)%,Sup-B15与OP9共培养液组的早期凋亡细胞百分数明显低于Sup-B15单独培养液组,差异有统计学意义(P〈0.05)。Western blot法检测结果显示,Sup-B15单独培养组、Sup-B15与OP9共培养组、Sup-B15与灭活的OP9共培养组、Sup-B15与OP9共培养液组、OP9单独培养液组和Sup-B15单独培养液组Sup-B15细胞中bcl-2蛋白的相对表达量分别为1.00±0.00、1.53±0.03、1.38±0.01、1.26±0.05、1.03±0.01和0.98±0.02,Sup-B15与OP9共培养组、Sup-B15与灭活的OP9共培养组Sup-B15细胞中bcl-2蛋白表达量均高于Sup-B15单独培养组(P〈0.05);Sup-B15与OP9共培养液组Sup-B15细胞中bcl-2蛋白的表达量明显高于Sup-B15单独培养液组(P〈0.05),而OP9单独培养液组与Sup-B15单独培养液组的差异无统计学意义(P〉0.05)。结论骨髓基质细胞OP9及其细胞外基质成分和基质细胞因子等骨髓微环境成分参与诱导了Sup-B15细胞对Ara-C的化疗抵抗。 Objective To investigate the influences of bone marrow stromal cells, components of extracellular matrix and cytokine secreted by stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells to cytosine arabinoside (Ara-C). Methods The co-culture model of acute lymphoblastic leukemia cell Sup-B15 and bone marrow stromal cell OP9 was constructed. Sup-B15 cells were cultured alone or co-cultured with OP9 cells, inactivated OP9 cells, the conditional medium (CM) of co-cultured OP9 cells and Sup-B15 cells, the CM of OP9 cells alone or Sup-B15 cells alone, respectively. The effects of different concentrations of Ara-C on the proliferation of each Sup-B1 cell group mentioned above were detected by cell counting kit-8 (CCK-8) method. The effects of different concentrations of Ara-C on the apoptosis of each group were detected by flow cytometry (FCM). The expressions of Bcl-2 protein in each group were detected by western blot. Results The results of CCK-8 test showed that the inhibitory efficiency of Ara-C was in a dose-dependent manner. With different concentrations of Ara-C treatment for 48 hours, the half maximal inhibitory concentrations (IC50) of Sup-B15 and OP9 co-cultured group, Sup-B15 and inactivated OP9 co-cultured group were 0.510 and 0.339 μg/ml, respectively, significantly higher than 0.091 μg/ml of Sup-B15 cultured alone group (P〈0.05). The IC50 of CM of Sup-B15 and OP9 co-cultured group was 0.204 μg/ml, significantly higher than 0.087 μg/ml of the CM of OP9 cultured alone group (P〈0.05) and 0.097 μg/ml of the CM of Sup-B15 cultured alone group (P〈0.05). The results of flow cytometry showed that with 0.10 μg/ml Ara-C treatment for 24 hours, the early apoptotic cell percentages of Sup-B15 and OP9 co-cultured group, Sup-B15 and inactivated OP9 co-cultured group and Sup-B15 cultured alone group were (6.67±2.19) %, (8.95±3.04) % and (20.46±2.63) %, respectively. The early apoptotic cell percentages of Sup-B15 and OP9 co-cultured group, Sup-B15 and inactivated OP9 co-cultured group were significantly lower than that of Sup-B15 cultured alone group (P〈0.05). The early apoptotic cell percentages of the CM of Sup-B15 and OP9 co-cultured group, the CM of OP9 cultured alone group and the CM of Sup-B15 cultured alone group were (11.16±2.97)%, (22.08±2.71)% and (19.25±1.57)%, respectively, the former two of which were significantly lower than the last one (P〈0.05). The results of western blot showed that the relative expression levels of Bcl-2 protein of Sup-B15 cultured alone group, Sup-B15 and OP9 co-cultured group, Sup-B15 and inactivated OP9 co-cultured group, the CM of Sup-B15 and OP9 co-cultured group, the CM of OP9 cultured alone group and the CM of Sup-B15 cultured alone group were 1.00±0.00, 1.53±0.03, 1.38±0.01, 1.26±0.05, 1.03±0.01 and 0.98±0.02, respectively. The expression levels of bcl-2 protein of three combined groups were significantly higher than that of Sup-B15 cultured alone group (P〈0.05). while no statistically significant difference was observed between the CM of OP9 cultured alone group and the CM of Sup-B15 cultured alone group (P〉0.05). Conclusion Bone marrow stromal cell OP9, the components of bone marrow extracellular matrix and cytokine secreted by stromal cells are involved in the induction of the chemotherapeutic resistance of Sup-B15 cells to Ara-C.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2017年第12期885-890,共6页 Chinese Journal of Oncology
基金 国家自然科学基金(30901753)
关键词 白血病细胞 骨髓基质细胞 微环境 耐药 Leukemia, acute lymphoblastic Bone marrow stromal cell Microenvironment Drug resistance
  • 相关文献

参考文献4

二级参考文献56

  • 1张剑白,孙媛,董娟,刘丽晓,宁芳.儿童急性白血病初治患者LRP和MRP的表达及其临床意义[J].癌症,2005,24(8):1015-1017. 被引量:2
  • 2秦慧,刘霆,杨金亮,黄欣,柳斌,宋鑫,赵霞,魏于全.蛋白质组学方法筛选维甲酸耐药相关蛋白[J].中华医学杂志,2007,87(8):520-525. 被引量:8
  • 3陈幸华,高蕾,张曦,王吉刚,张诚,彭贤贵,李忠俊,曾东风,刘耀,司英健.新型白血病骨髓基质细胞黏附介导耐药模型构建的探索性研究[J].中华医学杂志,2007,87(20):1380-1383. 被引量:4
  • 4王丹,克晓燕,王晶,徐芳,胡永芳.MDR1基因多态性与急性髓细胞白血病化学疗法结果的相关性研究[J].中华医学杂志,2007,87(20):1384-1388. 被引量:3
  • 5Hazlehurst LA, Dalton WS. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev, 2001, 20: 43-50.
  • 6Wang L, Fortney JE, Gibson LF. Stromal cell protection of B- lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt. Leuk Res, 2004, 28: 733-742.
  • 7Denkers IA, de-Jong-de-Boer TJ, Beelen RH, et al. Adhesive capacity of human long-term bone marrow oulture from normals and patients with acute myeloid leukemia: the influence of adhesion molecules. Leu Res, 1993,17: 255-261.
  • 8Denkers IA,Beelen RH, Ossenkoppele GJ, et al. Differences of cellular composition and adhesion molecule expression in "leukemic" as compared with " normal" human long-term bone marrow cultures. ANN Hematol, 1992, 64: 210-216.
  • 9Sognier MA, Zhang Y, Eberie RL,et al. Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line(LZ-100). Biochem Pharmacol, 1994, 48: 391-401.
  • 10Hazlehurst LA, Dalton WS. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev, 2001 , 20: 43-50.

共引文献30

同被引文献32

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部